Integrin beta 4/CD104 Antibody (450-9D) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NB100-63326
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # 450-9D
Concentration
0.1 mg/ml
Product Specifications
Immunogen
Purified alpha6 beta4 integrin from A431 cells
Reactivity Notes
Predicted cross-reactivities: Ferret, Mink, Mustelid
Specificity
NB100-65599 recognizes the human beta4 integrin (also known as CD104), a 205kD glycoprotein which associates with the alpha6 integrin to form the alpha6/beta4 complex. CD104 is expressed on epithelial cells, Schwann cells and various tumour cell lines. NB100-65599 recognizes an extracellular epitope on the CD104 molecule.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for Integrin beta 4/CD104 Antibody (450-9D) [FITC]
Application
Recommended Usage
Flow Cytometry
1:10-1:1000
Application Notes
For Flow Cytometry: Use 10 ul of the suggested working dilution to label 10^6 cells in 100 ul. The epitope recognised by this antibody is reported to be sensitive to formaldehyde fixation and tissue
processing. The use of acetone fixation for frozen sections is recommended.
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
PBS
Preservative
0.09% Sodium Azide
Concentration
0.1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Integrin beta 4/CD104
Additional Integrin beta 4/CD104 Products
Product Documents for Integrin beta 4/CD104 Antibody (450-9D) [FITC]
Product Specific Notices for Integrin beta 4/CD104 Antibody (450-9D) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...